Women with heart disease ‘still disadvantaged’
Female patients with heart disease remain disadvantaged, and the profession is male dominated, the American Heart Association says
Women make up only 38% of participants enrolled in cardiovascular trials despite heart disease being the number one killer of women worldwide, the American Heart Association says.
In the fourth annual ‘Science Goes Red’ issue of its flagship journal Circulation, the peak body has once again turned the spotlight on the underrepresentation of women that still pervades the specialty.
From participation rates in clinical trials to female representation on cardiology journal editorial boards, the association says there are many reasons women are still disadvantaged compared with men.
Here are four of them:
